Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-κB activity

Journal of General Virology

Volumn 80, Issue 12, 1999, Pages 3227-3232

  Bloss, Tim ^a,b   Kaykas, Ajamete ^a   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; PROLINE;

AMINO TERMINAL SEQUENCE; ARTICLE; DELETION MUTANT; EPSTEIN BARR VIRUS; PRIORITY JOURNAL;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0032727485     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-12-3227     Document Type: Article

References (32)

1. Arden, J. R., Segredo, Z., Wang, J., Lameh, J. & Sadee, W. (1995). Phosphorylation and agonist-specific trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. Journal of Neurochemistry 65, 1636-1645.
2. Baichwal, V. R. & Sugden, B. (1987). Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. Journal of Virology 61, 866-875.
3. Cicchetti, P., Mayer, B. J., Thiel, G. & Baltimore, D. (1992). Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257, 803-806.
4. Clausse, B., Fizazi, K., Walczak, V., Tetaud, C., Wiels, J., Tursz, T. & Busson, P. (1997). High concentrations of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology 228, 285-293.
5. Feng, S., Chen, J. K., Yu, H., Simon, J. A. & Schreiber, S. L. (1994). Two binding orientations for peptides to the src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247.
6. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D. & Hammerschmidt, W. (1997). Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO Journal 16, 6131-6140.
7. Grussenmeyer, T., Scheidtmann, K. H., Hutchinson, M. A., Eckhart, W. & Walter, G. (1985). Complexes of polyoma virus medium T antigen and cellular proteins. Proceedings of the National Academy of Sciences, USA 82, 7952-7954.
8. Hammarskjold, M. & Simurda, M. C. (1992). Epstein-Barr virus latent membrane protein transactivates the HIV type 1 long terminal repeat through induction of NF-KB activity. Journal of Virology 66, 6496-6501.
9. Izumi, K. M., Kaye, K. M. & Kieff, E. D. (1994). Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. Journal of Virology 68, 4369-4376.
10. Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein-1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, USA 90, 9150-9154.
11. Kieser, A., Kilger, E., Gires, O., Ueffing, M., Kolch, W. & Hammerschmidt, W. (1997). Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO Journal 16, 6478-6485.
12. Kilger, E., Kieser, A., Baumann, M. & Hammerschmidt, W. (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO Journal 17, 1700-1709.
13. Koch, C. A., Anderson, D., Moran, M. F., Ellis, C. & Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.
14. Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F. & Dixit, V. M. (1992). The Epstein-Barr virus LMP-1 gene product induces A20 zinc finger protein expression by activating NF-KB. Journal of Biological Chemistry 267, 24157-24160.
15. Liebowitz, D., Wang, D. & Kieff, E. (1986). Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. Journal of Virology 58, 233-237.
16. Liebowitz, D., Kopan, R., Fuchs, E., Sample, J. & Kieff, E. (1987). An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7, 2299-2308.
17. Mann, K. P. & Thorley-Lawson, D. (1987). Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. Journal of Virology 61, 2100-2108.
18. Mann, K. P., Staunton, P. & Thorely-Lawson, D. (1985). Epstein-Barr virus-encoded protein found in the plasma membrane of transformed cells. Journal of Virology 55, 710-720.
19. Martin, J. & Sugden, B. (1991a). The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth and Differentiation 2, 653-660.
20. Martin, J. & Sugden, B. (1991b). Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization and cytoskeletal association. Journal of Virology 65, 3246-3258.
21. Mayer, B. J. & Baltimore, D. (1993). Signaling through SH2 and SH3 domains. Trends in Cell Biology 3, 8-13.
22. Miller, W. E., Edwards, R. H., Walling, D. M. & Raab-Traub, N. (1994). Sequence variation in the Epstein-Barr virus latent membrane protein 1. Journal of General Virology 75, 2729-2740.
23. Mitchell, T. & Sugden, B. (1995). Stimulation of NF-KB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. Journal of Virology 69, 2968-2976.
24. Paulie, S., Rosen, A., Ehlin-Henriksson, B., Braesch-Andersen, S., Jakobson, E., Koho, H. & Perlmann, P. (1989). The human B lymphocyte and carcinoma antigen Cdw40, is a phosphoprotein involved in growth signal transduction. Journal of Immunology 142, 590-595.
25. Ren, R., Mayer, B., Cicchetti, P. & Baltimore, D. (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161.
26. Rothe, M., Sarma, V., Dixit, V. M. & Goeddel, D. V. (1995). TRAF2-mediated activation of NF-KB by TNR receptor 2 and CD40. Science 269, 1424-1427.
27. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Introduction of recombinant vectors into mammalian cells. In Molecular Cloning: A Laboratory Manual, 2nd edn, pp. 16.30-16.40. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
28. Sandberg, M., Hammerschmidt, W. & Sugden, B. (1997). Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. Journal of Virology 71, 4649-4656.
29. Sandvej, K., Gratama, J. W., Munch, M., Zhou, X., Bolhuis, R. L. H., Andresen, B. S., Gregersen, N. & Hamitton-Dutoit, S. (1997). Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90, 323-330.
30. Speck, S. H. & Strominger, J. L. (1989). Transcription of Epstein-Barr virus in latently infected, growth transformed lymphocytes. In Tumorigenic DNA Viruses: Advances in Viral Oncology, vol. 8, pp. 133-150. Edited by G. Klein. New York: Raven Press.
31. Wilson, P. T. & Bourne, H. R. (1995). Fatty acylation of alpha z: effects of palmitoylation and myristoylation on alpha z signaling. Journal of Biological Chemistry 270, 9667-9675.
32. Wilson, I. A., Niman, H. L., Houghten, R. A., Cherenson, A. R., Connolly, M. L. & Lerner, R. A. (1984). The structure of an antigenic determinant in a protein. Cell 37, 767-778.